GRAIL

Early multi-cancer detection

GRAIL is a healthcare company pioneering technologies for early cancer detection, combining next-generation sequencing, population-scale clinical studies and advanced computer and data science against one of medicine's hardest problems. The premise is straightforward and enormous: cancer mortality is driven substantially by stage at diagnosis, so detecting disease earlier changes outcomes more than treating it better does. The organisation brings together scientists, engineers and physicians, and is headquartered in the California Bay Area with locations in Washington DC, North Carolina and the United Kingdom.